agilon health, inc. (NYSE:AGL) Shares Sold by Capital World Investors

Capital World Investors trimmed its holdings in agilon health, inc. (NYSE:AGL - Free Report) by 4.3% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 46,308,236 shares of the company's stock after selling 2,059,773 shares during the period. Capital World Investors owned approximately 11.24% of agilon health worth $87,986,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in AGL. Capital International Investors grew its position in agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock worth $8,629,000 after buying an additional 1,498,524 shares during the period. JPMorgan Chase & Co. boosted its position in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after buying an additional 1,083,492 shares during the period. Alberta Investment Management Corp purchased a new position in shares of agilon health during the fourth quarter worth $1,564,000. Finally, Renaissance Technologies LLC boosted its position in shares of agilon health by 155.1% during the fourth quarter. Renaissance Technologies LLC now owns 463,300 shares of the company's stock worth $880,000 after buying an additional 281,700 shares during the period.

agilon health Stock Up 1.8 %

agilon health stock traded up $0.07 during midday trading on Friday, reaching $3.89. The company's stock had a trading volume of 3,612,723 shares, compared to its average volume of 4,840,107. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market cap of $1.61 billion, a P/E ratio of -4.14 and a beta of 0.38. The business has a 50-day simple moving average of $4.19 and a 200-day simple moving average of $3.14.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on AGL shares. TD Cowen raised their price target on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Sanford C. Bernstein upgraded agilon health from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Citigroup upgraded agilon health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $3.25 to $5.00 in a research note on Friday. Finally, Stifel Nicolaus increased their price objective on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research note on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, agilon health currently has a consensus rating of "Hold" and an average price target of $4.81.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.